RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $125
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $135 to $125.
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $135 to $125.
